Denna sida använder cookies. För mer information kan du läsa om kakor här.
Logotyp
Logotyp

Graviditet i samband med beroende - Referenser

  1. Magnusson A, Lundholm C, Goransson M, Copeland W, Heilig M, Pedersen NL: Familial influence and childhood trauma in female alcoholism. Psychol Med 2011;1-9. PubMed
  2. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, True W, Lin N, Toomey R, Eaves L: Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 1998;55:967-72. PubMed
  3. Copeland WE, Magnusson A, Goransson M, Heilig MA: Genetic moderators and psychiatric mediators of the link between sexual abuse and alcohol dependence. Drug Alcohol Depend 2010. PubMed
  4. Howell EM, Heiser N, Harrington M: A review of recent findings on substance abuse treatment for pregnant women. J Subst Abuse Treat 1999;16:195-219. PubMed
  5. Göranson M, Magnusson Å: Kvinnor och alkohol. Diagnos,riskbruk och beroende Stockholm, Liber, 2012
  6. Heffner JL, Blom TJ, Anthenelli RM: Gender differences in trauma history and symptoms as predictors of relapse to alcohol and drug use. Am J Addict 2011;20:307-11. PubMed
  7. Heilig M: Beroendetillstånd. Lund: Studentlitteratur, 2011
  8. Magnusson A, Goransson M, Heilig M: Hazardous alcohol users during pregnancy: psychiatric health and personality traits. Drug Alcohol Depend 2007;89:275-81. PubMed
  9. Shand FL, Degenhardt L, Slade T, Nelson EC: Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence. Addict Behav 2011;36:27-36. PubMed
  10. Statens Folkhälsoinstitut: Narkotikabruket i Sverige; Statens Folkhälsoinstitut, 2010
  11. Magnusson A, Goransson M, Heilig M: Unexpectedly high prevalence of alcohol use among pregnant Swedish women: failed detection by antenatal care and simple tools that improve detection. J Stud Alcohol 2005;66:157-64. PubMed
  12. Drogutvecklingen i Sverige 2017. Centralförbundet för alkohol- och narkotikaupplysning, CAN
  13. Carlen C, Johansson A, Lundblad E, Envall E-K: Barnmorskans guide för samtal om alkohol. Statens Folkhälsoinstitut, 2009
  14. Bakstad B, Welle-Strand G: Nasjonal retningslinje for gravide i legemiddelassistert rehabilitering(LAR) og oppfölging av familiene frem til barnet når skolealder. Helsedirektoratet, Oslo 2011.
  15. Greenfield SF, Back SE, Lawson K, Brady KT: Substance abuse in women. Psychiatr Clin North Am 2010;33:339-55. PubMed
  16. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-18. PubMed
  17. Wilens TE: The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. J Clin Psychiatry 2007;68 Suppl 11:4-8. PubMed
  18. Kuczkowski KM: The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol 2007;19:578-85. Pubmed 2
  19. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 Suppl 20:22-33. PubMed
  20. Niccols A, Milligan K, Smith A, Sword W, Thabane L, Henderson J: Integrated programs for mothers with substance abuse issues and their children: a systematic review of studies reporting on child outcomes. Child Abuse Negl 2012;36:308-22. PubMed
  21. Niccols A, Milligan K, Sword W, Thabane L, Henderson J, Smith A: Integrated programs for mothers with substance abuse issues: A systematic review of studies reporting on parenting outcomes. Harm Reduct J 2012;9:14. PubMed
  22. Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G: Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. 2008;103:1429-40. PubMed
  23. Lester BM, Twomey JE: Treatment of substance abuse during pregnancy. Womens Health (Lond Engl ) 2008;4:67-77. PubMed
  24. Nordfors M, Höjer I. Kvinnors erfarenhet av stöd från Mödra_Barnhälsovårdsteamet i Haga. FoU-rapport 4:2012;2012. Länsstyrelsen
  25. Opioid Abuse, Dependence, and Addictionin Pregnancy. Obstet Gynecol 2012;119:1070-6. PubMed
  26. Huxtable CA, Roberts LJ, Somogyi AA, MacIntyre PE. Acute pain management in opioidtolerant patients: a growing challenge. Anaesth Intensive Care 2011 Sep;39(5):804-23. PubMed
  27. Strathearn L, Mamun AA, Najman JM, O'Callaghan MJ: Does breastfeeding protect against substantiated child abuse and neglect? A 15-year cohort study. Pediatrics 2009;123:483-93. PubMed
  28. Uvnas-Moberg K, Petersson M: [Oxytocin--biochemical link for human relations. Mediator of antistress, well-being, social interaction, growth, healing...]. PubMed, Läkartidningen 2004;101:2634-9
  29. Rolfhamre L, Svensson K, Zwedberg S: Till dig som inte ammar, 2011
  30. Jansson LM, Choo R, Velez ML, Harrow C, Schroeder JR, Shakleya DM, Huestis MA: Methadone maintenance and breastfeeding in the neonatal period. Pediatrics 2008;121:106-14. PubMed
  31. Lindemalm S, Nydert P, Svensson JO, Stahle L, Sarman I: Transfer of buprenorphine into breast milk and calculation of infant drug dose. J Hum Lact 2009;25:199-205. PubMed
  32. Narcotic addiction in pregnancy with adverse maternal and perinatal outcome. - Lam, S.K., To, W.K., Duthie, S.J., Ma, H.K. Aust. N. Z. J. Obstet. Gynaecol. 1992; 32: 216-221. PubMed
  33. Maternal and fetal effects of heroin addiction during pregnancy. Little BB, Snell LM, Klein VR, Gilstrap LC 3rd, Knoll KA, Breckenridge JD. J Reprod Med. 1990; 35(2): 159-62. PubMed
  34. Kakko J, Heilig M, Sarman I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: Comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend 2008; 96: 69-78. PubMed 3
  35. Neonatal Drug Withdrawal. THE COMMITTEE ON DRUGS and THE COMMITTEE ON FETUS AND NEWBORN. Mark L. Hudak, Rosemarie C. Tan. Pediatrics 2012; 129; e540-560). PubMed
  36. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Agthe AG, Kim GR, Mathias KB, Hendrix CW, Chavez-Valdez R, Jansson L, Lewis TR, Yaster M, Gauda EB. Pediatrics. 2009 May; 123(5): e849-56. PubMed
  37. The Effects of Maternally Administered Methadone, Buprenorphine and Naltrexone on Offspring: Review of Human and Animal Data. W.O Farid, S.A Dunlop, R.J Tait, G.K Hulse. Curr Neuropharmacol. 2008 June; 6(2): 125–150. PubMed
  38. Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications. Minnes S, Lang A, Singer L. Addict Sci Clin Pract. 2011 Jul;6(1): 57-70. PubMed
  39. Neuroimaging of prenatal drug exposure. Dow-Edwards DL, Benveniste H, Behnke M, Bandstra ES, Singer LT, Hurd YL, Stanford LR. Neurotoxicol Teratol. 2006; 28(3):386-402. PubMed
  40. Diffusion Tensor Imaging of Frontal White Matter and Executive Functioning in CocaineExposed Children. Tamara Duckworth Warner, Marylou Behnke, Fonda Davis Eyler, Kyle Padgett, Christiana Leonard, Wei Hou, Cynthia Wilson Garvan, Ilona M. Schmalfuss, Stephen J. Blackband. Pediatrics. 2006 November; 118(5): 2014–2024). PubMed
  41. The influence of environmental factors on behavioural problems in 8-year-old children exposed to amphetamine during fetal life. Billing L, Eriksson M, Jonsson B, Steneroth G, Zetterström R. Child Abuse Negl. 1994 Jan;18(1):3-9. PubMed
  42. Cognitive outcomes in prenatal methamfetamine exposed childrein age six to seven years. Kwiakowski MA, Donald KA, Stein DJ, Thomas KGF, Roos A. Comprehensive Psychiatry. 2018 Jan; 24-33. PubMed
  43. Cannabis use during pregnancy: its effects on offspring from birth to young adulthood. Fried PA. in Alcohol, drugs and medication in pregnancy. Eds Preece PM, Riley EP. 2011 Mac Keith Press. U,K. Länsstyrelsen
  44. Moe V, Slinning K. Prenatal drug exposure and the conceptualization of long-term effects. Scand J Psychol 2002; 43: 41-7. PubMed
  45. Ornoy A. The impact of intrauterine exposure versus postnatal environment in neurodevelopmental toxicity: long-term neurobehavioural studies in children at risk for developmental disorders. Toxicol Lett 2003; 140-141: 171-81. PubMed
  46. Langtidseffekter hos barnet ved bruk av metadon/buprenorfin (og andre opioider) svangerskapet. Norske Helsedirektoratet 2017;1-36
  47. Volumetric cerebral characteristics of children exposed to opiates and other substances in utero. K. B. Walhovd, V. Moe1, K. Slinning, P. Due-Tønnessen, A. Bjørnerud, A. M. Dale, A. van der Kouwe, B. T. Quinn, B. Kosofsky, D. Greve, B. Fischl. Neuroimage. 2007 July 15;36(4): 1331–1344. PubMed
  48. Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications. Minnes S, Lang A, Singer L. Addict Sci Clin Pract. 2011 Jul;6(1):57-70. PubMed
  49. Neurobehavioural development of preschool-age children born to addicted mothers given opiate maintenance treatment with buprenorphine during pregnancy. Sundelin Wahlsten V, Sarman I. Acta Paediatr. 2013; 102(5): 544-9. PubMed
  50. Mechanisms of action of drugs of abuse on the developin brain.CJ Malanga, B E Kosofsky. In Clinics in Perinatology. Ed B M Lester. 1999. W.B. Saunders Company USA. PubMed
Publicerad: 2014/02/14 Senast uppdaterad: 2019/04/15

Webbplatsen produceras av Region Stockholm. Frågor och synpunkter om innehållet tas emot av redaktionen på:

psykiatristod.hsf@sll.se